AmpliPhi Biosciences (APHB) Reports Q2 Loss of $1.46, Miss on Revenues

AmpliPhi Biosciences (NYSE: APHB) reported Q2 EPS of ($1.46). Revenue for the quarter came in at $28 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on AmpliPhi Biosciences (APHB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79